Couverture de Cancer Horizons

Cancer Horizons

Cancer Horizons

De : CURE Talks Cancer
Écouter gratuitement

À propos de ce contenu audio

 A weekly podcast powered by CURE, on what we do best: provide Cancer Updates Research and Education.


Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum - ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones.


As the largest consumer magazine in the United States for patient, survivors and caregivers, we strive to combine science with humanity to make cancer understandable.


To learn more, you can also visit us on Facebook, Twitter and Instagram!


 Hygiène et vie saine Psychologie Psychologie et psychiatrie Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

      S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments
      Dec 31 2025
      CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berger, who recently spoke at CURE’s Educated Patient® Metastatic Breast Cancer Summit, is an assistant professor of medicine at Columbia University Irving Medical Center Division of Hematology and Medical Oncology and the associate director of breast medical oncology at New York Presbyterian-Hudson Valley Hospital in New York.

      Key points discussed by Berger in the podcast included the importance of personalized medicine, with treatments tailored to tumor and patient characteristics. Immunotherapy, particularly Keytruda (pembrolizumab), is often used, especially for PDL-1 positive patients. PARP inhibitors are recommended for BRCA mutation-positive patients. Antibody-drug conjugates, like Trodelvy (sacituzumab govitecan), are emerging as effective treatments, shown to be superior to chemotherapy in combination with immunotherapy.

      Additionally, patients are encouraged to be active in their treatment decisions, engage in exercise and proper nutrition, and consider enrolling in clinical trials, while caregivers are advised to support patients by understanding their needs and providing appropriate assistance.
      Afficher plus Afficher moins
      15 min
    • S7 Ep1: The Importance of Spotting Endometrial Cancer

      S7 Ep1: The Importance of Spotting Endometrial Cancer
      Mar 18 2025
      Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
      Afficher plus Afficher moins
      10 min
    • S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

      S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care
      Sep 17 2024
      20 min
    Aucun commentaire pour le moment